Sign in Create account
Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export price history as CSV.
Sign in and upgrade to a paid plan to export futures history as CSV.

Lactose (India) Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524202
₹107.10
▲ 2.30 (2.19%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
37/100
Weak
Valuation
80/100
Undervalued
Momentum
49/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹135 Cr
PE (TTM)
19.5
Industry median 36.1 (152 companies)
Price to Book
2.1
PEG (TTM)
0.3
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-51.1
Free Cash Flow
₹-5 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
57.98%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-31.53%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
34.91%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
142.20%
as of Dec. 31, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
18.68%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.10
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.95
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
2.70
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
4.10%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
10.64%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
8.90%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
2.25%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
14.67%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
6.36%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.95)
  • No Return on equity is 15% or more (6.4%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (26.1% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
2.2%
Low 101.1000 · High 108.0000
1W return
-3.0%
Low 101.1000 · High 114.8500
1M return
0.5%
Low 97.5000 · High 114.8500
52W return
-51.1%
Low 97.0500 · High 117.8000
Lifetime High ₹219.1500 (Dec. 24, 2024)
Lifetime Low ₹0.5900 (July 19, 2007)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
106.9
10D
106.0
20D
106.3
50D
117.0
100D
125.3
200D
128.1

Delivery and volume

Day avg. delivery
79.9%
Week avg. delivery
78.4%
Month avg. delivery
79.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

105.40
Pivot
First resistance109.70
Second resistance112.30
Third resistance116.60
First support102.80
Second support98.50
Third support95.90
Day RSI48.4
Day MFI63.6
Day MACD-2.27
Day MACD signal-4.27

Beta

1M2.56
3M1.61
1Y1.61
3Y0.63

Price change analysis

↑ 0.5%
Over 1 Month
LowHigh
97.50114.85
↓ -51.1%
Over 3 Months
LowHigh
97.05117.80
↓ -51.1%
Over 6 Months
LowHigh
97.05117.80
↓ -51.1%
Over 1 Year
LowHigh
97.05117.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 19.5 (own history: 25.1–62.9)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹47 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹1.8800

Ranks #132 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter53.65%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 53.65% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 10 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
29 Feb 2024 ANKIT AGARWAL Bulk Sell 86,562 147.9000 BSE
22 Apr 2019 MABLE RAJESH Bulk Buy 51,000 28.0100 BSE
23 Feb 2018 MANGAL SAVITRI BIZCON PRIVATE LIMITED Bulk Sell 109,277 120.0000 BSE
12 Sep 2017 MANGAL SAVITRI BIZCON PRIVATE LIMITED Bulk Buy 86,903 188.7700 BSE
31 Aug 2017 SANTOSH BHANSALI HUF Bulk Sell 76,000 185.0000 BSE
11 Jul 2017 ALAUKIK MINES AND POWER P LTD Bulk Sell 73,300 130.0000 BSE
15 Jun 2017 MANGAL SAVITRI BIZCON PRIVATE LIMITED Bulk Buy 10,346 146.1500 BSE
15 Jun 2017 MANGAL SAVITRI BIZCON PRIVATE LIMITED Bulk Sell 53,950 155.0000 BSE
15 Jun 2017 ALAUKIK MINES AND POWER P LTD Bulk Buy 55,300 155.0000 BSE
24 May 2017 RAJESH JOSEPH Bulk Buy 49,000 115.1700 BSE

All bulk and block deals →

Corporate Announcements

All 8 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Lactose India Ltd - 524202 - Disclosure Of Voting Results Of The Of 35Th Annual General Meeting Of Lactose India Limited (''Company'') Held On 30Th September, 2026
1 Oct 2026 AGM/EGM Lactose India Ltd - 524202 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Lactose India Ltd - 524202 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Company Update Lactose India Ltd - 524202 - Announcement under Regulation 30 (LODR)-Change in Management
29 Sep 2026 Insider Trading / SAST Lactose India Ltd - 524202 - Closure of Trading Window
8 Sep 2026 Company Update Lactose India Ltd - 524202 - Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep 2026 Company Update Lactose India Ltd - 524202 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
5 Sep 2026 Company Update Lactose India Ltd - 524202 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (18.7%)

Weaknesses

  • Low Return on Equity (6.4%)
  • Thin net profit margin (4.1%)

Opportunities

  • PEG below 1 (0.34) -- earnings growth outpacing its own valuation

Threats

  • Down 51.1% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Lactose (India) Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.